Aclarion, Inc. Common Stock (ACON) Stock Price

ACONStock

$2.49−63.56%52W

Market Cap$7.18M

P/E—

PEG Ratio—

Div yield—

Beta1.29

ACON Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-4.42%

Price vs S&P 500 (4W)21.83%

VGM Score46.15

Book Value / Share (Quarterly)$8.04

P/TBV (Annual)4.47x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.83%

Cash Flow / Share (Quarterly)$-3.06

Price vs S&P 500 (YTD)-54.13%

Gross Margin (TTM)19.34%

Net Profit Margin (TTM)-10336.12%

EPS (TTM)$-9.56

10-Day Avg Trading Volume0.08M

EPS Excl Extra (TTM)$-9.56

Revenue Growth (5Y)9.28%

EPS (Annual)$-13.60

ROI (Annual)-720.92%

Gross Margin (Annual)9.02%

Net Profit Margin (5Y Avg)-10254.64%

Cash / Share (Quarterly)$7.77

Revenue Growth QoQ (YoY)11.32%

ROA (Last FY)-329.86%

Revenue Growth TTM (YoY)42.56%

EBITD / Share (TTM)$-8.23

Operating Margin (TTM)-10975.27%

Cash Flow / Share (Annual)$-4.56

P/B Ratio0.35x

P/B Ratio (Quarterly)0.38x

Net Income / Employee (Annual)$-657,600

EV / Revenue (TTM)-155.20x

Net Interest Coverage (TTM)-12.07x

ROA (TTM)-51.71%

EPS Incl Extra (Annual)$-13.60

Current Ratio (Annual)0.71x

Quick Ratio (Quarterly)19.35x

3-Month Avg Trading Volume0.08M

52-Week Price Return-63.56%

Revenue / Employee (TTM)$7,100

Tangible BV / Share (Quarterly)$7.53

P/S Ratio (Annual)91.35x

Asset Turnover (Annual)0.02x

52-Week High$12.03

Operating Margin (5Y Avg)-8982.77%

EPS Excl Extra (Annual)$-13.60

CapEx CAGR (5Y)2.64%

26-Week Price Return6.83%

Quick Ratio (Annual)0.56x

13-Week Price Return-18.40%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)19.65x

Enterprise Value$-12.09M

Revenue / Share Growth (5Y)7.44%

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$6,900

Pretax Margin (Annual)-9551.87%

Cash / Share (Annual)$1.30

3-Month Return Std Dev60.65%

Gross Margin (5Y Avg)-19.88%

Net Income / Employee (TTM)$-731,800

ROE (Last FY)-720.92%

Net Interest Coverage (Annual)-31.92x

EPS Basic Excl Extra (Annual)$-13.60

Receivables Turnover (TTM)2.61x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-9.56

Receivables Turnover (Annual)4.73x

ROI (TTM)-54.41%

P/S Ratio (TTM)88.83x

Pretax Margin (5Y Avg)-10254.64%

Revenue / Share (Annual)$0.14

Tangible BV / Share (Annual)$2.07

Price vs S&P 500 (52W)-81.87%

Year-to-Date Return-42.17%

5-Day Price Return2.31%

EPS Normalized (Annual)$-13.60

ROA (5Y Avg)-278.57%

Net Profit Margin (Annual)-9551.87%

Month-to-Date Return18.22%

Cash Flow / Share (TTM)$-0.52

EBITD / Share (Annual)$-13.95

Operating Margin (Annual)-10103.97%

EPS Basic Excl Extra (TTM)$-9.56

P/TBV (Quarterly)0.41x

P/B Ratio (Annual)1.55x

Pretax Margin (TTM)-10336.12%

Book Value / Share (Annual)$4.53

Price vs S&P 500 (13W)-21.20%

Beta1.29x

Revenue / Share (TTM)$0.04

ROE (TTM)-54.41%

52-Week Low$1.95

gGradeB

mGradeD

vgmGradeC

ACON Earnings Surprise History

Q2 25-2.75est. -2.26

Q3 25-2.93est. -2.64

Q4 25-4.52est. -3.60

Q1 26-1.34est. -1.55

Q2 26-1.12est. -1.05

ACON Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
ACONAclarion, Inc. Common Stock	—	B	D	$2.49
NTRANatera, Inc. Common Stock	F	A	A	$336.71
LHLabcorp Holdings Inc.	C	D	B	$337.68
DGXQuest Diagnostics Inc.	C	D	B	$244.51
GHGuardant Health, Inc. Common Stock	F	A	A	$164.92
CAICaris Life Sciences, Inc. Common Stock	F	A	B	$28.01
RDNTRadNet, Inc. Common Stock	D	C	C	$76.86
BLLNBillionToOne, Inc. Class A Common Stock	F	F	C	$100.08
CELCCelcuity Inc. Common Stock	—	—	D	$92.27
GRALGRAIL, Inc. Common Stock	D	A	B	$82.54
VCYTVeracyte, Inc.	D	A	C	$44.04
CDNACareDx, Inc.	D	B	A	$50.80
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.25
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.27
FRNMFreenome, Inc. Common stock	—	F	A	$13.99
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	B	$12.07
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$35.00
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.95
YDESYD Bio Limited Ordinary Shares	—	—	D	$4.68
BDSXBiodesix, Inc. Common Stock	D	B	A	$28.07
XGNExagen Inc. Common Stock	D	B	B	$7.60
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$9.80
SERASera Prognostics, Inc. Class A Common Stock	D	D	C	$2.18
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.79
ADVBAdvanced Biomed Inc. Common Stock	A	—	B	$9.18
AMSAmerican Shared Hospital Services	A	C	D	$1.47
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	D	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.36

About Aclarion, Inc. Common Stock

Aclarion Inc provides Nociscan, a SaaS diagnostic platform that uses proprietary Magnetic Resonance Spectroscopy technology to help physicians noninvasively identify painful spinal discs. The company generates revenue by delivering diagnostic reports to medical professionals in the United States.